(0.26%) 5 535.75 points
(0.22%) 39 555 points
(0.28%) 19 984 points
(0.69%) $82.10
(-1.88%) $2.55
(0.25%) $2 345.50
(0.07%) $29.58
(-0.44%) $997.50
(-0.25%) $0.931
(-0.26%) $10.65
(-0.17%) $0.789
(2.07%) $87.50
Live Chart Being Loaded With Signals
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide...
Stats | |
---|---|
本日の出来高 | 3.21M |
平均出来高 | 1.65M |
時価総額 | 10.18B |
EPS | $-0.550 ( Q3 | 2024-05-08 ) |
次の収益日 | ( $0.460 ) 2024-09-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-8.68 (Sector) 49.64 (Industry) 35.32 |
ATR14 | $0.0240 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-04 | Hopson Ricky | Sell | 1 401 | Common Stock |
2024-03-15 | Gunther Scott | Sell | 387 | Common Stock |
2024-01-25 | Kreuzburg Christa | Sell | 523 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 6 071 | Common Stock |
2024-01-16 | Hatzfeld Michael | Buy | 3 981 | Options to purchase Common Stock |
INSIDER POWER |
---|
69.89 |
Last 95 transactions |
Buy: 316 064 | Sell: 55 780 |
ボリューム 相関
Catalent Inc 相関
10 最も負の相関 | |
---|---|
BBAI-WT | -0.939 |
RTO | -0.921 |
OAK-PB | -0.918 |
OAK-PA | -0.916 |
SRFM | -0.907 |
CCG | -0.906 |
CRI | -0.904 |
AIZN | -0.902 |
BYON | -0.898 |
QBTS-WT | -0.889 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Catalent Inc 相関 - 通貨/商品
Catalent Inc 財務諸表
Annual | 2023 |
収益: | $4.28B |
総利益: | $1.06B (24.79 %) |
EPS: | $-1.280 |
FY | 2023 |
収益: | $4.28B |
総利益: | $1.06B (24.79 %) |
EPS: | $-1.280 |
FY | 2022 |
収益: | $4.83B |
総利益: | $1.64B (33.97 %) |
EPS: | $2.74 |
FY | 2021 |
収益: | $4.00B |
総利益: | $1.35B (33.82 %) |
EPS: | $3.15 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Catalent Inc
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。